Brian Austen

3.3k total citations
113 papers, 2.7k citations indexed

About

Brian Austen is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Brian Austen has authored 113 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 33 papers in Physiology and 18 papers in Cell Biology. Recurrent topics in Brian Austen's work include Alzheimer's disease research and treatments (32 papers), Chemical Synthesis and Analysis (14 papers) and RNA and protein synthesis mechanisms (12 papers). Brian Austen is often cited by papers focused on Alzheimer's disease research and treatments (32 papers), Chemical Synthesis and Analysis (14 papers) and RNA and protein synthesis mechanisms (12 papers). Brian Austen collaborates with scholars based in United Kingdom, United States and Tanzania. Brian Austen's co-authors include Omar M. A. El‐Agnaf, Emma R. Frears, Huw Davies, David Stephens, Claire E. Walters, Richard B. Parsons, John Hermon-Taylor, D.G. Smyth, David Allsop and Emil L. Smith and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Brian Austen

111 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Austen United Kingdom 31 1.5k 1.1k 411 351 284 113 2.7k
Martin Herbst Germany 13 1.0k 0.7× 1.1k 1.0× 395 1.0× 156 0.4× 224 0.8× 25 2.5k
Danny M. Hatters Australia 35 2.6k 1.7× 1.1k 0.9× 549 1.3× 304 0.9× 119 0.4× 79 4.0k
Anthony J. Turner United Kingdom 33 1.6k 1.1× 1.3k 1.1× 694 1.7× 211 0.6× 244 0.9× 90 3.3k
Janetta G. Culvenor Australia 41 1.5k 1.0× 1.5k 1.3× 811 2.0× 137 0.4× 273 1.0× 83 5.0k
Frances Prelli United States 42 4.2k 2.7× 2.8k 2.5× 332 0.8× 129 0.4× 331 1.2× 89 5.6k
Gerald W. Becker United States 30 1.6k 1.0× 658 0.6× 468 1.1× 136 0.4× 916 3.2× 53 4.0k
Keld Fosgerau Denmark 18 2.1k 1.4× 383 0.3× 398 1.0× 448 1.3× 154 0.5× 33 3.6k
David B. Glass United States 29 2.6k 1.7× 418 0.4× 405 1.0× 183 0.5× 123 0.4× 46 3.4k
Xiaodong Cheng United States 37 3.4k 2.2× 485 0.4× 626 1.5× 319 0.9× 426 1.5× 102 5.0k
Hans‐Gottfried Genieser Germany 32 2.9k 1.9× 545 0.5× 723 1.8× 571 1.6× 195 0.7× 82 4.3k

Countries citing papers authored by Brian Austen

Since Specialization
Citations

This map shows the geographic impact of Brian Austen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Austen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Austen more than expected).

Fields of papers citing papers by Brian Austen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Austen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Austen. The network helps show where Brian Austen may publish in the future.

Co-authorship network of co-authors of Brian Austen

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Austen. A scholar is included among the top collaborators of Brian Austen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Austen. Brian Austen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matharu, Balpreet, Nick J. Spencer, Franklyn A. Howe, & Brian Austen. (2015). Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease. Neuropeptides. 53. 63–70. 10 indexed citations
2.
Cerasoli, Eleonora, Maxim G. Ryadnov, & Brian Austen. (2015). The elusive nature and diagnostics of misfolded Aβ oligomers. Frontiers in Chemistry. 3. 17–17. 23 indexed citations
3.
Spencer, Nicholas G., et al.. (2013). Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain. NeuroImage. 76. 108–115. 27 indexed citations
4.
5.
Turner, Paul R., et al.. (2009). Molecular interactions of the plasma membrane calcium ATPase 2 at pre- and post-synaptic sites in rat cerebellum. Neuroscience. 162(2). 383–395. 32 indexed citations
6.
Austen, Brian, et al.. (2008). HLA Homology within the C5 Domain Promotes Peptide Binding by HIV Type 1 gp120. AIDS Research and Human Retroviruses. 24(6). 845–855. 13 indexed citations
7.
Parsons, Richard B., et al.. (2007). A specific inhibitor of cholesterol biosynthesis, BM15.766, reduces the expression of β‐secretase and the production of amyloid‐βin vitro. Journal of Neurochemistry. 102(4). 1276–1291. 11 indexed citations
8.
Ambroggio, Ernesto E., Brian Austen, & Gerardo D. Fidelio. (2007). Biophysical properties of a synthetic transit peptide from wheat chloroplast ribulose 1,5‐bisphosphate carboxylase. Journal of Peptide Science. 13(4). 245–252. 4 indexed citations
9.
El‐Agnaf, Omar M. A., et al.. (2004). Properties of Neurotoxic Peptides Related to the Bri Gene. Protein and Peptide Letters. 11(3). 207–212. 9 indexed citations
10.
Parsons, Richard B., et al.. (2004). The regulation of β-secretase by cholesterol and statins in Alzheimer's disease. Journal of the Neurological Sciences. 229-230. 269–273. 21 indexed citations
11.
Austen, Brian. (2003). Peptide Synthesis. Humana Press eBooks. 3. 311–332. 2 indexed citations
13.
Austen, Brian, et al.. (2001). Inhibition of antigen transport by expression of infected cell peptide 47 (ICP47) prevents cell surface expression of HLA in choriocarcinoma cell lines. Journal of Reproductive Immunology. 50(1). 19–40. 10 indexed citations
15.
El‐Agnaf, Omar M. A., et al.. (2000). Oligomerization and Toxicity of β-Amyloid-42 Implicated in Alzheimer's Disease. Biochemical and Biophysical Research Communications. 273(3). 1003–1007. 168 indexed citations
16.
Frears, Emma R., David Stephens, Claire E. Walters, Huw Davies, & Brian Austen. (1999). The role of cholesterol in the biosynthesis of β-amyloid.. Neuroreport. 10(8). 1699–1705. 274 indexed citations
17.
Patel, Sarju & Brian Austen. (1996). Substitution of Fifty Four Homologue (Ffh) in Escherichia coli with the Mammalian 54–kDa Protein of Signal‐Recognition Particle. European Journal of Biochemistry. 238(3). 760–768. 11 indexed citations
18.
He, Mingyue, Hong Liu, & Brian Austen. (1994). Expression and Export in Escherichia coli of Fusion Proteins Containing Carboxy-Terminally Located Honeybee Prepromelittin. DNA and Cell Biology. 13(8). 875–882. 2 indexed citations
19.
Robinson, Andrew, Mingyue He, Olwyn M.R. Westwood, & Brian Austen. (1993). Changes in levels of pancreatic endoplasmic reticulum proteins that function in translocation and maturation of secretory proteins in response to cholecystokinin. Cytotechnology. 11(3). 197–204. 2 indexed citations
20.
Austen, Brian, et al.. (1988). Allergenic Properties of the Genetic Variants A and B of Bovine Beta-Lactoglobulin. International Archives of Allergy and Immunology. 86(2). 245–248. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026